Predictive and prognostic value of circulating tumor cell detection in lung cancer: A clinician's perspective

Critical Reviews in Oncology/Hematology

Volumn 93, Issue 2, 2015, Pages 90-102

  Tognela, Annette ^a,c,e,f   Spring, Kevin J ^a,c,d   Becker, Therese ^a,c,d   Caixeiro, Nicole J ^a,c   Bray, Victoria J ^b   Yip, Po Yee ^f,g   Chua, Wei ^b,c   Lim, Stephanie H ^a,b,c,d   de Souza, Paul ^a,b,c,d,e  

^a INGHAM INSTITUTE FOR APPLIED MEDICAL RESEARCH   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c South Western Sydney Clinical School   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e UNIVERSITY OF WESTERN SYDNEY   (Australia)

^f CAMPBELLTOWN HOSPITAL   (Australia)

^g UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Biomarkers; Circulating tumor cells; Lung cancer; Non small cell; Small cell

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; B RAF KINASE; DISCOIDIN; DISCOIDIN DOMAIN RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPITHELIAL CELL ADHESION MOLECULE; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FIBROBLAST GROWTH FACTOR RECEPTOR 1; K RAS PROTEIN; LIVER KINASE B1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOTRANSFERASE; PROTEIN P53; RETINOBLASTOMA 1; RETINOBLASTOMA PROTEIN; SCATTER FACTOR RECEPTOR; THYROID TRANSCRIPTION FACTOR 1; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; TUMOR MARKER;

CANCER PROGNOSIS; CANCER STAGING; CELLSEARCH; CHEMORADIOTHERAPY; CIRCULATING TUMOR CELL; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; EARLY DIAGNOSIS; GENE; GENE MUTATION; HUMAN; ISOLATION BY SIZE OF EPITHELIAL TUMOR CELL; LOBECTOMY; METASTASIS INHIBITION; METHODOLOGY; MICROFLUIDICS; MOLECULAR BIOLOGY; NON SMALL CELL LUNG CANCER; OBP 401 ASSAY; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PROGRESSION FREE SURVIVAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RET GENE; REVIEW; ROS1 GENE; SMALL CELL LUNG CANCER; SURGICAL TECHNIQUE; VIDEO ASSISTED THORACOSCOPIC SURGERY; BIOASSAY; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CELL COUNT; CELL SEPARATION; DEVICES; GAMMA RADIATION; LUNG NEOPLASMS; PATHOLOGY; PROCEDURES; PROGNOSIS; PROSPECTIVE STUDY; SINGLE CELL ANALYSIS; THERAPEUTIC USE; TUMOR EMBOLISM;

ANTINEOPLASTIC AGENTS; BIOLOGICAL ASSAY; BIOPSY; CARCINOMA, NON-SMALL-CELL LUNG; CELL COUNT; CELL SEPARATION; EARLY DIAGNOSIS; GAMMA RAYS; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; PROGNOSIS; PROSPECTIVE STUDIES; SINGLE-CELL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84927145251     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2014.10.001     Document Type: Review

References (92)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA: Cancer J Clin 2011, 61:69-90.
2. Lassen U., Osterlind K., Hansen M., Dombernowsky P., Bergman B., Hansen H.H. Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years-an analysis of 1,714 consecutive patients. J Clin Oncol 1995, 13:1215-1220.
3. Groome P.A., Bolejack V., Crowley J.J., Kennedy C., Krasnik M., Sobin L.H., et al. The IASLC Lung Cancer Staging Project: validation of the proposals for revision of the T, N, and M descriptors and consequent stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol 2007, 2:694-705.
4. Young R., Pailler E., Billiot F., Drusch F., Barthelemy A., Oulhen M., et al. Circulating tumor cells in lung cancer. Acta Cytol 2012, 56:655-660.
5. O'Flaherty J.D., Gray S., Richard D., Fennell D., O'Leary J.J., Blackhall F.H., et al. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer. Lung Cancer 2012, 76:19-25.
6. Parkinson D.R., Dracopoli N., Petty B.G., Compton C., Cristofanilli M., Deisseroth A., et al. Considerations in the development of circulating tumor cell technology for clinical use. J Transl Med 2012, 10:138.
7. Krebs M.G., Metcalf R.L., Carter L., Brady G., Blackhall F.H., Dive C. Molecular analysis of circulating tumour cells-biology and biomarkers. Nat Rev Clin Oncol 2014, 11:129-144.
8. Hou J.M., Krebs M.G., Lancashire L., Sloane R., Backen A., Swain R.K., et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. J Clin Oncol 2012, 30:525-532.
9. Funaki S., Sawabata N., Nakagiri T., Shintani Y., Inoue M., Kadota Y., et al. Novel approach for detection of isolated tumor cells in pulmonary vein using negative selection method: morphological classification and clinical implications. Eur J Cardiothorac Surg 2011, 40:322-327.
10. Tanaka F., Yoneda K., Kondo N., Hashimoto M., Takuwa T., Matsumoto S., et al. Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res 2009, 15:6980-6986.
11. Hou J.M., Greystoke A., Lancashire L., Cummings J., Ward T., Board R., et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol 2009, 175:808-816.
12. Hofman V., Long E., Ilie M., Bonnetaud C., Vignaud J.M., Flejou J.F., et al. Morphological analysis of circulating tumour cells in patients undergoing surgery for non-small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method. Cytopathology 2012, 23:30-38.
13. Nieva J., Wendel M., Luttgen M.S., Marrinucci D., Bazhenova L., Kolatkar A., et al. High-definition imaging of circulating tumor cells and associated cellular events in non-small cell lung cancer patients: a longitudinal analysis. Phys Biol 2012, 9:016004.
14. Ma X.L., Xiao Z.L., Liu L., Liu X.X., Nie W., Li P., et al. Meta-analysis of circulating tumor cells as a prognostic marker in lung cancer. Asian Pac J Cancer Prev 2012, 13:1137-1144.
15. Wang J., Wang K., Xu J., Huang J., Zhang T. Prognostic significance of circulating tumor cells in non-small-cell lung cancer patients: a meta-analysis. PLoS One 2013, 8:e78070.
16. Bednarz-Knoll N., Alix-Panabières C., Pantel K. Clinical relevance and biology of circulating tumor cells. Breast Cancer Res 2011, 13:228.
17. Alix-Panabières C., Pantel K. Circulating tumor cells: liquid biopsy of cancer. Clin Chem 2013, 59:110-118.
18. Liberko M., Kolostova K., Bobek V. Essentials of circulating tumor cells for clinical research and practice. Crit Rev Oncol Hematol 2013, 88:338-356.
19. Allard W.J., Matera J., Miller M.C., Repollet M., Connelly M.C., Rao C., et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004, 10:6897-6904.
20. Fusi A., Metcalf R., Krebs M., Dive C., Blackhall F. Clinical utility of circulating tumour cell detection in non-small-cell lung cancer. Curr Treat Options Oncol 2013, 14:610-622.
21. Denlinger C.E., Ikonomidis J.S., Reed C.E., Spinale F.G. Epithelial to mesenchymal transition: the doorway to metastasis in human lung cancers. J Thorac Cardiovasc Surg 2010, 140:505-513.
22. Soltermann A., Tischler V., Arbogast S., Braun J., Probst-Hensch N., Weder W., et al. Prognostic significance of epithelial-mesenchymal and mesenchymal-epithelial transition protein expression in non-small cell lung cancer. Clin Cancer Res 2008, 14:7430-7437.
23. Chen Q., Ge F., Cui W., Wang F., Yang Z., Guo Y., et al. Lung cancer circulating tumor cells isolated by the EpCAM-independent enrichment strategy correlate with Cytokeratin 19-derived CYFRA21-1 and pathological staging. Clin Chim Acta 2013, 419:57-61.
24. Yasaka T., Mantich N.M., Boxer L.A., Baehner R.L. Functions of human monocyte and lymphocyte subsets obtained by countercurrent centrifugal elutriation: differing functional capacities of human monocyte subsets. J Immunol 1981, 127:1515-1518.
25. Wang S.Y., Mak K.F., Chen L.Y., Chou M.P., Ho C.K. Heterogeneity of human blood monocyte: two subpopulations with different sizes, phenotypes and functions. Immunology 1992, 77:298-303.
26. Vona G., Sabile A., Louha M., Sitruk V., Romana S., Schütze K., et al. Isolation by size of epithelial tumor cells: a new method for the immunomorphological and molecular characterization of circulating tumor cells. Am J Pathol 2000, 156:57-63.
27. Nagrath S., Sequist L., Maheswaran S., Bell D., Irimia D., Ulkus L., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239.
28. Sequist L.V., Nagrath S., Toner M., Haber D.A., Lynch T.J. The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients. J Thorac Oncol 2009, 4:281-283.
29. Maheswaran S., Sequist L.V., Nagrath S., Ulkus L., Brannigan B., Collura C.V., et al. Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 2008, 359:366-377.
30. Krebs M.G., Hou J.-M., Ward T.H., Blackhall F.H., Dive C. Circulating tumour cells: their utility in cancer management and predicting outcomes. Ther Adv Med Oncol 2010, 2:351-365.
31. Han Y., Su C., Liu Z. Methods for detection of circulating cells in non-small cell lung cancer. Front Biosci 2014, 19:896-903.
32. van Meerbeeck J.P., Fennell D.A., De Ruysscher D.K.M. Small-cell lung cancer. Lancet 2011, 378:1741-1755.
33. Nicholson S., Beasley M., Brambilla E., et al. Small cell lung carcinoma (SCLC): a clinicopathological study of 100 cases with surgical specimens. Am J Surg Pathol 2002, 26:1184-1197.
34. Rossi A., Maione P., Palazzolo G., Sacco P.C., Ferrara M.L., Falanga M., et al. New targeted therapies and small-cell lung cancer. Clin Lung Cancer 2008, 9:271-279.
35. Naito T., Tanaka F., Ono A., Yoneda K., Takahashi T., Murakami H., et al. Prognostic impact of circulating tumor cells in patients with small cell lung cancer. J Thorac Oncol 2012, 7:512-519.
36. Normanno N., Rossi A., Morabito A., Signoriello S., Bevilacqua S., Di Maio M., et al. Prognostic value of circulating tumor cells' reduction in patients with extensive small-cell lung cancer. Lung Cancer 2013, http://dx.doi.org/10.1016/j.lungcan.2014.05.002.
37. Hiltermann T.J.N., Pore M.M., van den Berg A., Timens W., Boezen H.M., Liesker J.J.W., et al. Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor. Ann Oncol 2012, 23:2937-2942.
38. Igawa S., Gohda K., Fukui T., Ryuge S., Otani S., Masago A., et al. Circulating tumor cells as a prognostic factor in patients with small cell lung cancer. Oncol Lett 2014, 7:1469-1473.
39. Morgensztern D., Ng S.H., Gao F., Govindan R. Trends in stage distribution for patients with non-small cell lung cancer: a national cancer database survey. J Thorac Oncol 2010, 5:29-33.
40. Reck M., Heigener D.F., Mok T., Soria J.C., Rabe K.F. Management of non-small-cell lung cancer: recent developments. Lancet 2013, 382:709-719.
41. Sienel W., Seen-Hibler R., Mutschler W., Pantel K., Passlick B. Tumour cells in the tumour draining vein of patients with non-small cell lung cancer: detection rate and clinical significance. Eur J Cardiothorac Surg 2003, 23:451-456.
42. Ge M.J., Shi D., Wu Q.C., Wang M., Li L.B. Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period. J Cancer Res Clin Oncol 2006, 132:248-256.
43. Rolle A., Gunzel R., Pachmann U., Willen B., Hoffken K., Pachmann K. Increase in number of circulating disseminated epithelial cells after surgery for nonsmall cell lung cancer monitored by MAINTRAC(R) is a predictor for relapse: a preliminary report. World J Surg Oncol 2005, 3:18.
44. Okumura Y., Tanaka F., Yoneda K., Hashimoto M., Takuwa T., Kondo N., et al. Circulating tumor cells in pulmonary venous blood of primary lung cancer patients. Ann Thorac Surg 2009, 87:1669-1675.
45. Hashimoto M., Tanaka F., Yoneda K., Takuwa T., Matsumoto S., Okumura Y., et al. Significant increase in circulating tumour cells in pulmonary venous blood during surgical manipulation in patients with primary lung cancer. Interact Cardiovasc Thorac Surg 2014, 18:775-783.
46. Yamashita J.I., Matsuo A., Kurusu Y., Saishoji T., Hayashi N., Ogawa M. Preoperative evidence of circulating tumor cells by means of reverse transcriptase-polymerase chain reaction for carcinoembryonic antigen messenger RNA is an independent predictor of survival in non-small cell lung cancer: a prospective study. J Thorac Cardiovasc Surg 2002, 124:299-305.
47. Kurusu Y., Yamashita J.I., Ogawa M. Detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction in patients with resectable non-small-cell lung cancer. Surgery 1999, 126:820-826.
48. Yamashita J.I., Kurusu Y., Fujino N., Saisyoji T., Ogawa M. Detection of circulating tumor cells in patients with non-small cell lung cancer undergoing lobectomy by video-assisted thoracic surgery: a potential hazard for intraoperative hematogenous tumor cell dissemination. J Thorac Cardiovasc Surg 2000, 119:899-905.
49. Yan T.D., Black D., Bannon P.G., McCaughan B.C. Systematic review and meta-analysis of randomized and nonrandomized trials on safety and efficacy of video-assisted thoracic surgery lobectomy for early-stage non-small-cell lung cancer. J Clin Oncol 2009, 27:2553-2562.
50. Yoon S.O., Kim Y.T., Jung K.C., Jeon Y.K., Kim B.-H., Kim C-W. TTF-1 mRNA-positive circulating tumor cells in the peripheral blood predict poor prognosis in surgically resected non-small cell lung cancer patients. Lung Cancer 2011, 71:209-216.
51. Jerome Marson V., Mazieres J., Groussard O., Garcia O., Berjaud J., Dahan M., et al. Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade. Histopathology 2004, 45:125-134.
52. Xu B., Thong N., Tan D., Khoury T. Expression of thyroid transcription factor-1 in colorectal carcinoma. Appl Immunohistochem Mol Morph 2010, 18:244-249.
53. Ordonez N.G. Value of thyroid transcription factor-1 immunostaining in tumor diagnosis: a review and update. Appl Immunohistochem Mol Morphol 2012, 20:429-444.
54. Sawabata N., Okumura M., Utsumi T., Inoue M., Shiono H., Minami M., et al. Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method. Gen Thorac Cardiovasc Surg 2007, 55:189-192.
55. Hofman V., Bonnetaud C., Ilie M.I., Vielh P., Vignaud J.M., Flejou J.F., et al. Preoperative circulating tumor cell detection using the isolation by size of epithelial tumor cell method for patients with lung cancer is a new prognostic biomarker. Clin Cancer Res 2011, 17:827-835.
56. Sheu C.C., Yu Y.P., Tsai J.R., Chang M.Y., Lin S.R., Hwang J.J., et al. Development of a membrane array-based multimarker assay for detection of circulating cancer cells in patients with non-small cell lung cancer. Int J Cancer 2006, 119:1419-1426.
57. Hofman V., Ilie M.I., Long E., Selva E., Bonnetaud C., Molina T., et al. Detection of circulating tumor cells as a prognostic factor in patients undergoing radical surgery for non-small-cell lung carcinoma: comparison of the efficacy of the CellSearch AssayTM and the isolation by size of epithelial tumor cell method. Int J Cancer 2011, 129:1651-1660.
58. Went P.T.H., Lugli A., Meier S., Bundi M., Mirlacher M., Sauter G., et al. Frequent EpCam protein expression in human carcinomas. Hum Pathol 2004, 35:122-128.
59. Shi D., Li L., Wang M., Ge M., Wu Q. Fluctuation of circulating tumor cells in patients with lung cancer by real-time fluorescent quantitative-PCR approach before and after radiotherapy. J Cancer Res Ther 2005, 1:221-226.
60. Chen T.F., Jiang G.L., Fu X.L., Wang L.J., Qian H., Wu K.L., et al. CK19 mRNA expression measured by reverse-transcription polymerase chain reaction (RT-PCR) in the peripheral blood of patients with non-small cell lung cancer treated by chemo-radiation: an independent prognostic factor. Lung Cancer 2007, 56:105-114.
61. Tarumi S., Gotoh M., Kasai Y., Matsuura N., Okuda M., Go T., et al. Innovative method using circulating tumor cells for prediction of the effects of induction therapy on locally advanced non-small cell lung cancer. J Cardiothorac Surg 2013, 8:175.
62. Isobe K., Hata Y., Kobayashi K., Hirota N., Sato K., Sano G., et al. Clinical significance of circulating tumor cells and free DNA in non-small cell lung cancer. Anticancer Res 2012, 32:3339-3344.
63. Punnoose E.A., Atwal S., Liu W., Raja R., Fine B.M., Hughes B.G.M., et al. Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib. Clin Cancer Res 2012, 18:2391-2401.
64. Krebs M.G., Hou J.M., Sloane R., Lancashire L., Priest L., Nonaka D., et al. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches. J Thorac Oncol 2012, 7:306-315.
65. Krebs M.G., Sloane R., Priest L., Lancashire L., Hou J.M., Greystoke A., et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 2011, 29:1556-1563.
66. Muinelo-Romay L., Vieito M., Abalo A., Nocelo M., Barón F., Anido U., et al. Evaluation of circulating tumor cells and related events as prognostic factors and surrogate biomarkers in advanced NSCLC patients receiving first-line systemic treatment. Cancers 2014, 6:153-165.
67. Juan O., Vidal J., Gisbert R., Muñoz J., Maciá S., Gómez-Codina J. Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine. Clin Transl Oncol 2014, 16:637-643.
68. Wu C., Hao H., Li L., Zhou X., Guo Z., Zhang L., et al. Preliminary investigation of the clinical significance of detecting circulating tumor cells enriched from lung cancer patients. J Thorac Oncol 2009, 4:30-36.
69. Hirose T., Murata Y., Oki Y., Sugiyama T., Kusumoto S., Ishida H., et al. Relationship of circulating tumor cells to the effectiveness of cytotoxic chemotherapy in patients with metastatic non-small-cell lung cancer. Oncol Res 2012, 20:131-137.
70. Sher Y.P., Shih J.Y., Yang P.C., Roffler S.R., Chu Y.W., Wu C.W., et al. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes. Clin Cancer Res 2005, 11:173-179.
71. Das M., Riess J.W., Frankel P., Schwartz E., Bennis R., Hsieh H.B., et al. ERCC1 expression in circulating tumor cells (CTCs) using a novel detection platform correlates with progression-free survival (PFS) in patients with metastatic non-small-cell lung cancer (NSCLC) receiving platinum chemotherapy. Lung Cancer 2012, 77:421-426.
72. Christoph D.C., Hoffmann A.C., Gauler T.C., Asuncion B.R., Loewendick H., Peglow A., et al. Detection of circulating lung cancer cells with strong thymidylate synthase reactivity in the peripheral blood of a patient with pulmonary adenocarcinoma treated with pemetrexed. J Thorac Oncol 2012, 7:766-767.
73. Becker T.M., Caixeiro N.J., Lim S.H., Tognela A., Kienzle N., Scott K.F., et al. New frontiers in circulating tumor cell analysis-a reference guide for biomolecular profiling towards translational clinical use. Int J Cancer 2014, 134:2523-2533.
74. Liu L., Liao G., He P., Zhu H., Liu P., Qu Y., et al. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes. Biochem Biophys Res Commun 2008, 372:756-760.
75. 18F-FDG PET uptake in patients with treatment-naive non-small cell lung cancer. PLoS One 2013, 8:e67733.
76. Larsen J.E., Minna J.D. Molecular biology of lung cancer: clinical implications. Clin Chest Med 2011, 32:703-740.
77. Cooper W.A., Lam D.C.L., O'Toole S.A., Minna J.D. Molecular biology of lung cancer. J Thoracic Dis 2013, 5:S479-S490.
78. Breitenbuecher F., Hoffarth S., Worm K., Cortes-Incio D., Gauler T.C., Köhler J., et al. Development of a highly sensitive and specific method for detection of circulating tumor cells harboring somatic mutations in non-small-cell lung cancer patients. PLoS One 2014, 9:e85350.
79. Ilie M., Long E., Butori C., Hofman V., Coelle C., Mauro V., et al. ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma. Ann Oncol 2012, 23:2907-2913.
80. Ni X., Zhuo M., Su Z., Duan J., Gao Y., Wang Z., et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci 2013, 110:21083-21088.
81. Pailler E., Adam J., Barthélémy A., Oulhen M., Auger N., Valent A., et al. Detection of circulating tumor cells harboring a unique ALK rearrangement in ALK-positive non-small-cell lung cancer. J Clin Oncol 2013, 31:2273-2281.
82. Stovold R., Blackhall F., Meredith S., Hou J., Dive C., White A. Biomarkers for small cell lung cancer: neuroendocrine, epithelial and circulating tumour cells. Lung Cancer 2012, 76:263-268.
83. Hou J.M., Krebs M., Ward T., Sloane R., Priest L., Hughes A., et al. Circulating tumor cells as a window on metastasis biology in lung cancer. Am J Pathol 2011, 178:989-996.
84. Lecharpentier A., Vielh P., Perez-Moreno P., Planchard D., Soria J.C., Farace F. Detection of circulating tumour cells with a hybrid (epithelial/mesenchymal) phenotype in patients with metastatic non-small cell lung cancer. Br J Cancer 2011, 105:1338-1341.
85. Nel I., Jehn U., Gauler T., Hoffmann A.C. Individual profiling of circulating tumor cell composition in patients with non-small cell lung cancer receiving platinum based treatment. Transl Lung Cancer Res 2014, 3:100-106.
86. Reckamp K.L., Figlin R.A., Burdick M.D., Dubinett S.M., Elashoff R.M., Strieter R.M. CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer. BMC Cancer 2009, 9:213.
87. Yie S.M., Lou B., Ye S.R., He X., Cao M., Xie K., et al. Clinical significance of detecting survivin-expressing circulating cancer cells in patients with non-small cell lung cancer. Lung Cancer 2009, 63:284-290.
88. Hodgkinson C.L., Morrow C.J., Li Y., Metcalf R.L., Rothwell D.G., Trapani F., et al. Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer. Nat Med 2014, 20:897-903.
89. Shi W.L., Li J., Du Y.J., Zhu W.F., Wu Y., Hu Y.M., et al. CK-19 mRNA-positive cells in peripheral blood predict treatment efficacy and survival in small-cell lung cancer patients. Med Oncol 2013, 30:1-8.
90. Du Y.J., Li J., Zhu W.F., Wu Y., Tang X.P., Wang Y., et al. Survivin mRNA-circulating tumor cells predict treatment efficacy of chemotherapy and survival for advanced non-small cell lung cancer patients. Tumor Biol 2014, 35:4499-4507.
91. Pantel K., Brakenhoff R.H., Brandt B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 2008, 8:329-340.
92. Gerges N., Rak J., Jabado N. New technologies for the detection of circulating tumour cells. Br Med Bull 2010, 94:49-64.